Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
39.89
+2.80 (7.55%)
At close: Mar 6, 2026
-2.23%
Market Cap 17.76B
Revenue (ttm) 1.56B
Net Income (ttm) -553.29M
Shares Out 445.34M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE 47.49
Dividend n/a
Ex-Dividend Date n/a
Volume 4,841,699
Average Volume 2,144,416
Open 37.09
Previous Close 37.09
Day's Range 37.05 - 40.50
52-Week Range 34.61 - 89.04
Beta 0.85
RSI 46.31
Earnings Date Apr 23, 2026

About Sinocelltech Group

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar for the treatment of various autoimmune diseases; Anbezu, a bevacizumab biosimilar for the ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,242
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.